About
Male
David Bonita is based out of New York, New York, and is the General Partner at OrbiMed. David Bonita is the Board of Director at Inmagene Biopharmaceuticals. David previously served as the Board of Director at Clementia Pharmaceuticals. David Bonita attended Harvard University.
Experience
Morgan Stanley Tactical Value
View →Financial Analyst · 1998 – 1999
15kAngel Investment · Banking
- Board of Director · ImageneBio2025 – present
- Board Member · Windward Bio2025 – present
- Board Member · Sublimity Therapeutics2018 – present
- Board Director · Ambit Biosciences
- Director · CardiAQ Valve Technologies
- Board Member · Ikena Oncology
- Board Member · Imara
- Board Of Director · Repare Therapeutics
- Board Member · Third Harmonic Bio
- Board Member · Tricida
Education
- Columbia University · MBA– 2004
- Harvard University · BA, Biology– 1997
- Columbia University · M.D.
OrbiMed Portfolio (1)
Magenta Medical
Medical DevicesVenture83 emp
People at OrbiMed
Data from: crunchbase
